Trade Summary

6 days ago, Szela Mary T, serving as CEO, Pres at Trisalus Life Sciences, Inc. (TLSI), purchased 39,682 shares at $2.59 per share, for a total transaction value of $102,776.00. Following this transaction, Szela Mary T now holds 1,065,215 shares of TLSI.

This purchase represents a 4.00% increase in Szela Mary T's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 4:42 PM ET, 3 days after the trade was made.

Trisalus Life Sciences, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.